Patent · US Expired

Composite antibodies of human subgroup IV light chain capable of binding to TAG-72

US5976845A · kind A · utility

14Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateNov 2, 1999
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/622
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention concerns a subset of composite Hum4 V.sub.L, V.sub.H antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have variable regions with (1) V.sub.L segments derived from the human subgroup IV germline gene, and (2) a V.sub.H segment which is capable of combining with the V.sub.L to form a three dimensional structure having the ability to bind TAG-72. In vivo methods of treatment and diagnostic assay using these composite antibodies is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.